Marek Pruszyński - Concepedia

Author

Marek Pruszyński

Instytut Chemii i Techniki Jądrowej ORCID

Also Known As

M. Pruszynski, M. Pruszyński, Marek Pruszynski, Marek Pruszyński, Pruszyński, Marek

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Instytut Chemii i Techniki Jądrowej Duke Medical Center University of Warsaw Joint Research Centre Vrije Universiteit Brussel

About

Marek Pruszyński is an author at Instytut Chemii i Techniki Jądrowej specializing in natural sciences, engineering, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	6	6	399
2	Natural Sciences	6	6	153
3	Medicine	5	5	139
4	Biochemistry	5	5	82
5	Applied Physics	1	1	71

Marek Pruszyński

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment Matthias D’Huyvetter, Jens De Vos, Catarina Xavier, Clinical Cancer Research	2017	173
Evaluation of an Anti-HER2 Nanobody Labeled with <sup>225</sup>Ac for Targeted α-Particle Therapy of Cancer Marek Pruszyński, Matthias D’Huyvetter, Frank Bruchertseifer, Molecular Pharmaceutics	2018	113
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody Marek Pruszyński, Eftychia Koumarianou, Ganesan Vaidyanathan, Nuclear Medicine and Biology NanomedicineBreast OncologyEngineeringBreast CancerTumor Targeting	2012	103
Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application Marek Pruszyński, Natalia S. Loktionova, D. V. Filosofov, Applied Radiation and Isotopes Electrical EngineeringEngineeringElectrophysiologyInstrumentationElectronic Instrumentation	2010	102
Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer Ł. Dziawer, Agnieszka Majkowska‐Pilip, Damian Gaweł, Nanomaterials	2019	97
Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc Marek Pruszyński, Agnieszka Majkowska‐Pilip, Natalia S. Loktionova, Applied Radiation and Isotopes Positron Annihilation Spectroscopy	2012	90
Improved Tumor Targeting of Anti-HER2 Nanobody Through <i>N</i>-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling Marek Pruszyński, Eftychia Koumarianou, Ganesan Vaidyanathan, Journal of Nuclear Medicine	2014	83
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer Edyta Cędrowska, Marek Pruszyński, Weronika Gawęda, Molecules	2020	80
New measurement of excitation functions for (p,x) reactions on natMo with special regard to the formation of 95mTc, 96m+gTc, 99mTc and 99Mo O. Lebeda, Marek Pruszyński Applied Radiation and Isotopes New MeasurementEngineeringNuclear PhysicsPhysicsNatural Sciences	2010	71
Gold nanoparticle bioconjugates labelled with <sup>211</sup>At for targeted alpha therapy Przemysław Koźmiński, Sylwia Męczyńska‐Wielgosz, Marek Pruszyński, RSC Advances NanoparticlesEngineeringBiomedical EngineeringGold NanoparticlesNanomedicine	2017	58

Page 1